Amazon.com, Inc. AMZN shares were trading lower on Friday, potentially following positive reports on a coronavirus clinical trial and U.S. initiatives to reopen the economy.
Gilead Sciences, Inc. GILD remdesivir is a potential COVID-19 treatment.
E-commerce companies have benefited from store closings, with Amazon first among them, and may be reacting to the possibility of stores reopening.
Amazon shares were trading down 2.18% at $2,355.68 at the time of publication Friday afternoon. The stock has a 52-week high of $2,461 and a 52-week low of $1,626.03.
Related Links:
Amazon's To Roll Out $700M Employee Advancement Program
How The COVID-19 Pandemic Makes Amazon, Netflix Key Businesses
Photo courtesy of Amazon.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
